Literature DB >> 15037140

Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy.

A Saifuddin1, B S Mann, S Mahroof, J A S Pringle, T W R Briggs, S R Cannon.   

Abstract

AIM: To describe the use of MRI to identify and biopsy areas of dedifferentiation in patients with a suspected diagnosis of dedifferentiated chondrosarcoma.
MATERIALS AND METHODS: Low-grade chondrosarcoma is characterized at magnetic resonance imaging (MRI) as having a lobulate, hyperintense appearance on T2-weighted spin-echo sequences. T2-weighted MR images were assessed in 15 patients with a final pathological diagnosis of dedifferentiated chondrosarcoma for regions of atypical reduced signal intensity. Information regarding the site of ultrasound or computed tomography (CT)-guided biopsy was available in 10 cases.
RESULTS: Nine patients were male and six female with a mean age of 60 years (range 25-77 years). The sites involved were the distal femur (n+4) pelvis (n=3) proximal femur (n=4) femoral diaphysis (n=1) proximal humerus (n=2) and proximal tibia (n=1). The dedifferentiated component consisted of osteosarcoma (n=5) malignant fibrous histiocytoma (n=6) spindle cell sarcoma (n=1) leiomyosarcoma (n=1) and pleomorphic sarcoma (n=1). In 14 of the 15 cases, areas of lower signal intensity lacking in lobulation were identified. In nine of the 10 cases, biopsy site included such areas and yielded high-grade sarcoma.
CONCLUSIONS: Dedifferentiation within chondrosarcoma may be identified on T2-weighted MRI as areas of reduced signal intensity. These areas should be the preferred site of biopsy.

Entities:  

Mesh:

Year:  2004        PMID: 15037140     DOI: 10.1016/j.crad.2003.08.009

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  15 in total

Review 1.  [Cartilage tumors. Classification, conditions for biopsy and histologic characteristics].

Authors:  G Delling; B Jobke; S Burisch; M Werner
Journal:  Orthopade       Date:  2005-12       Impact factor: 1.087

2.  MRI guided needle localization in a patient with recurrence pleomorphic sarcoma and post-operative scarring.

Authors:  Ching-Di Chang; Jesse Wei; Jeffrey D Goldsmith; Mark C Gebhardt; Jim S Wu
Journal:  Skeletal Radiol       Date:  2017-03-09       Impact factor: 2.199

Review 3.  The imaging of cartilaginous bone tumours. II. Chondrosarcoma.

Authors:  H Douis; A Saifuddin
Journal:  Skeletal Radiol       Date:  2012-10-04       Impact factor: 2.199

Review 4.  [The importance of radiology in bone sarcoma diagnostics : Initial and advanced diagnostics].

Authors:  Volker Vieth
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

5.  The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21st century perspective.

Authors:  A M Davies; A Patel; C Azzopardi; S L James; R Botchu; L Jeys
Journal:  J Clin Orthop Trauma       Date:  2022-07-30

6.  Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.

Authors:  Jelena Sopta; Aleksandar Dordević; Goran Tulić; Vesna Mijucić
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-25       Impact factor: 4.553

7.  Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones?

Authors:  Pablo D Roitman; Germán L Farfalli; Miguel A Ayerza; D Luis Múscolo; Federico E Milano; Luis A Aponte-Tinao
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

Review 8.  The role of MRI in image-guided needle biopsy of focal bone and soft tissue neoplasms.

Authors:  M M Y Khoo; A Saifuddin
Journal:  Skeletal Radiol       Date:  2013-05-04       Impact factor: 2.199

Review 9.  Update on the imaging features of the enchondromatosis syndromes.

Authors:  Ban Sharif; Daniel Lindsay; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2021-07-24       Impact factor: 2.199

Review 10.  The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions.

Authors:  F Alyas; S L James; A M Davies; A Saifuddin
Journal:  Eur Radiol       Date:  2007-03-07       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.